Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00003760
Status:
COMPLETED
Last Update Posted:
2012-08-09
First Post:
1999-11-01
Brief Title:
Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
Sponsor:
The University of Texas Health Science Center at San Antonio
Organization:
The University of Texas Health Science Center at San Antonio
Organization Data
Organization:
The University of Texas Health Science Center at San Antonio
Class:
OTHER
Study ID:
CDR0000066884
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The University of Texas Health Science Center at San Antonio
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| University of Texas | OTHER |
| Merck Sharp Dohme LLC | INDUSTRY |